Big Pharma Split Corp.

TSX:PRM.TO

11.2 (CAD) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

20242023202220212020201920182017
Operating Activities:
Net Income -0.539-0.6452.3894.21-0.2172.582.105-0.318
Depreciation & Amortization 00000000
Deferred Income Tax 00000000
Stock Based Compensation 00000000
Change In Working Capital -0.0120.010.175-0.154-0.032-0.003-0.0540.054
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 00000000
Other Working Capital -0.0120.010.175-0.154-0.032-0.003-0.0540.649
Other Non Cash Items -0.74412.494-1.436-13.0564.5976.102-0.78-30.69
Operating Cash Flow -1.29611.8581.128-94.3488.6791.271-30.954
Investing Activities:
Investments In Property Plant And Equipment 0-0000000
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 00000000
Investing Cash Flow 00000000
Financing Activities:
Debt Repayment 1.2840000000
Common Stock Issued 0.34300.47.57400020.4
Common Stock Repurchased -0.469-5.32200-1.687-3.658-0.2650
Dividends Paid -1.504-2.109-1.866-2.218-1.233-1.484-2.2530
Other Financing Activities 0-5.040.96211.493-2.967-6.254-0.38212.335
Financing Cash Flow -0.346-12.471-1.73710.194-4.652-8.569-2.7132.735
Other Information:
Effect Of Forex Changes On Cash 0-0.003-0.0020.005-0.0010.0090.010.064
Net Change In Cash 0-0.615-0.6111.199-0.3050.119-1.4281.846
Cash At End Of Period 1.0310.2040.8191.430.2310.5360.4171.846